OtherSPECIAL CONTRIBUTION
MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy
Barry W. Wessels, Mark W. Konijnenberg, Roger G. Dale, Hazel B. Breitz, Marta Cremonesi, Ruby F. Meredith, Alan J. Green, Lionel G. Bouchet, A. Bertrand Brill, Wesley E. Bolch, George Sgouros and Stephen R. Thomas
Journal of Nuclear Medicine November 2008, 49 (11) 1884-1899; DOI: https://doi.org/10.2967/jnumed.108.053173
Barry W. Wessels
Mark W. Konijnenberg
Roger G. Dale
Hazel B. Breitz
Marta Cremonesi
Ruby F. Meredith
Alan J. Green
Lionel G. Bouchet
A. Bertrand Brill
Wesley E. Bolch
George Sgouros
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy
Barry W. Wessels, Mark W. Konijnenberg, Roger G. Dale, Hazel B. Breitz, Marta Cremonesi, Ruby F. Meredith, Alan J. Green, Lionel G. Bouchet, A. Bertrand Brill, Wesley E. Bolch, George Sgouros, Stephen R. Thomas
Journal of Nuclear Medicine Nov 2008, 49 (11) 1884-1899; DOI: 10.2967/jnumed.108.053173
MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy
Barry W. Wessels, Mark W. Konijnenberg, Roger G. Dale, Hazel B. Breitz, Marta Cremonesi, Ruby F. Meredith, Alan J. Green, Lionel G. Bouchet, A. Bertrand Brill, Wesley E. Bolch, George Sgouros, Stephen R. Thomas
Journal of Nuclear Medicine Nov 2008, 49 (11) 1884-1899; DOI: 10.2967/jnumed.108.053173
Related Articles
Cited By...
- The MIRD Schema for Radiopharmaceutical Dosimetry: A Review
- Rethinking Dosimetry: The Perils of Extrapolated External-Beam Radiotherapy Constraints to Radionuclide Therapy
- Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study
- Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
- A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy
- Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
- Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
- The Relevance of Dosimetry in Precision Medicine
- Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy
- RADAR Commentary: Evolution and Current Status of Dosimetry in Nuclear Medicine
- 4-Step Renal Dosimetry Dependent on Cortex Geometry Applied to 90Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by 90Y PET
- Dynamic and Static Small-Animal SPECT in Rats for Monitoring Renal Function After 177Lu-Labeled Tyr3-Octreotate Radionuclide Therapy
- Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
- Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy